MedTrace Logo

Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma

NCT04191434 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2022-07-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Flamboyant 125/12 association in adults with asthma.

Conditions

Interventions

DRUG

Flamboyant 125/12

Flamboyant 125/12 capsule

DRUG

Budesonide/formoterol 200/6

Budesonid/formoterol 200/6 capsule

OTHER

Flamboyant 125/12 Placebo

Flamboyant 125/12 Placebo capsule

OTHER

Budesonide/formoterol 200/6 placebo

Budesonid/formoterol 200/6 Placebo capsule

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-22
Primary Completion
2023-05-31
Completion
2023-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04191434 on ClinicalTrials.gov